Abstract
For many years it has been known that abnormal coagulation and fibrinolytic activity existed in the environs of malignant tumours. Whether these activities affected the invasiveness and metastatic activity of tumours has been in question for some time. The advent of precise assays for individual components of both coagulation and fibrinolysis has allowed a more precise analysis of the individual components of those systems which seem relevant to malignancy. While this report may not seem to fit ideally into an international meeting on Arterial Chemoreception it is felt that a wider perspective on receptors in disease may not go amiss. Thus we present herein a brief overview on the role of one component of the human fibrinolytic system, urinary-type plasminogen activator, uPA (also known as urokinase in the UK) and its receptor, called uPA receptor (e.g. u-PAR) in human malignancy. A brief comment is also given on a role for tissue plasminogen activator (tPA) in malignancy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Astedt, B. &Holmberg, L. (1976). Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture. Nature 261: 595–597.
Behrendt, N., Ronne, E., Ploug, M. et al. (1990). The human receptor for urokinase plasminogen activator. NH2 terminal amino acid sequence and glycosylation variants. J. Biol. Chem. 265: 6453–6460.
Cubellis, M. V., Nolli, M. L., Cassani, G. &Blasi, F. (1986). Binding of single chain prourokinase to the urokinase receptor of human U937 cells. J. Biol. Chem. 261: 15819–15822.
Duffy, M. J. (1993). Urokinase-type plasminogen activator and malignancy - Review. Fibrinolysis 7: 295–302.
Ellis, V., Scully, M. F. &Kakkar, V. V. (1989). Plasminogen activator initiated by single-chain urokinasetype plasminogen activator. Potentiation by U937 monocytes. J. Biol. Chem. 264: 2185–2188.
Evers, J. L., Patel, J., Madeja, J. et al. (1982). Plasminogen activator activity composition in human breast cancer. Cancer Res. 42: 219–226.
Ganesh, S., Verspaget, H., Sier, C. et al. (1992). Prognostic relevance of mucosal plasminogen activator levels in colorectal cancer. Fibrinolysis 6: (Suppl. 2), 103.
Gelister, J., Mahmoud, M., Lewin, M. R., Gaffney, P. J. &Boulos, P. B. (1986). Plasminogen activators in human colorectal neoplasms. Br. Med. J. 293: 728–731.
Gorelik, E. (1992). Protective effect of fibrin on tumour metastasis. Fibrinolysis 6: (Suppl. 1), 35–38.
Hasui, Y., Marutsuka, K., Suzumiya, J. et al. (1992). The content of urokinase-type plasminogen activator as a prognostic factor in urinary bladder cancer. Int. J. Cancer 50: 871–873.
Janicke, F., Schmitt, M., Ulm, K., Gossner, W. &Graeff, H. (1989). Urokinase-type plasminogen activator antigen and early relapse in breast cancer. Lancet ii: 1049.
Layer, G. T., Cederholm-Williams, S. A., Gaffney, P. J. et al. (1987). Urokinase - the enzyme responsible for invasion and metastasis in human breast carcinoma. Fibrinolysis 1: 237–240.
Oka, T., Ishida, T., Nishino, T. &Sugimachi, K. (1991). Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumours of pulmonary adenocarcinoma. Cancer Res. 51:3522–3525.
Plow, E. F., Freaney, D. E., Plescia, J. &Miles, L. A. (1986). The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J. Cell Biol. 103: 2411–2420.
Roldan, A. L., Cubellis, M. V., Masucci, M. T. et al. (1990). Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin-dependent proteolysis. EMBO J. 9: 467–474.
Tryggvason, K., Hoyhtya, M. &Salo, T. (1987). Proteolytic degradation of extracellular matrix in tumour invasion. Biochim. Biophys. Acta 907: 191–217.
Vassali, J.-D., Baccino, D. &Berlin, D. (1985). A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J. Cell Biol. 100: 86–92.
Yu, H. &Schultz, R. M. (1990). Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and artisense genes. Cancer Res. 50: 7623–7633.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gaffney, P.J., Cooke, D.A., Burnand, K.G. (1994). Urokinase and its Receptor: Markers of Malignancy?. In: O’Regan, R.G., Nolan, P., McQueen, D.S., Paterson, D.J. (eds) Arterial Chemoreceptors. Advances in Experimental Medicine and Biology, vol 360. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2572-1_25
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2572-1_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6099-5
Online ISBN: 978-1-4615-2572-1
eBook Packages: Springer Book Archive